Explorative Clinical Study on the Performance & Acceptance of New

Status Completed

Clinical Trial Summary

Performance and acceptance of new intermittent catheters tested in healthy volunteers

Clinical Trial Description

This study is a single blinded, randomised, crossover study. The study period consists of an information visit, an inclusion visit, three test visits and a termination visit.

Two prototypes of intermittent catheters (Test product 2 and 3) compared to the standard catheter SpeediCath® Flex (Comparator).

In the investigation ten subjects will be included. The subjects will be catheterised once per visit. The subjects will be catheterised with the two test catheters and comparator in a randomised order. The order of the catheterisations will be randomised to prevent bias.

During the test visits the primary, secondary and explorative endpoints will be registered.

Subjects will be asked to participate in an interview in continuation of their last visit (Test Visit 3). The interviews will be performed by a Coloplast representative asking questions related to their experience with the catheter.

The subjects must sign a separate consent form for this purpose and can participate in the investigation without participating in the interview. In addition, subjects will be asked for consent to tape recording and filming during the interviews, but can participate in interviews without this.

In addition, a Coloplast representative will interview the Investigator and her representatives after LPO with questions related to their experience with the catheters.

The investigation is planned to be conducted in August 2018-Januar 2019. The visit window will be minimum five days between the visits (catheterisations), to ensure time for healing of any potential urethral trauma. However, the maximum time between visits should be adjusted to ensure the subject is terminated before LPO.

No biobank will be established for this investigation. All urine samples in the clinical investigation (for evaluating in- and exclusion criteria and for evaluating end points) will be destructed immediately after analysis. ;

Study Design

Related Conditions & MeSH terms

Compliance, Patient

Clinical Trial Details

NCT number	NCT04231149
Study type	Interventional
Source	Coloplast A/S
Contact
Status	Completed
Phase	N/A
Start date	November 5, 2018
Completion date	December 20, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04874467` - Influence of Keratinized Mucosa on Dental Implants With Mucositis	N/A
Terminated	`NCT03266991` - Treatment of Latent Tuberculosis in Socially Marginalised Citizens	Phase 4
Not yet recruiting	`NCT06017063` - Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields	N/A
Recruiting	`NCT06411847` - The Effectiveness of Virtual Appointments on Compliance With Twin Block Wear	N/A
Completed	`NCT03748576` - A Prospective Randomized Controlled Trial of Mobile Medical Used for Management of Pregnant Women	N/A
Recruiting	`NCT05157113` - Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population	Phase 4
Recruiting	`NCT05231473` - Impact Of The Nurse Enhanced Recovery After Surgery Coordinator On The Compliance In Colorectal Surgery (nursERAS-BCN)	N/A
Completed	`NCT03925168` - Music Therapy and Dialysis: A Pilot Investigation Into the Effectiveness of Patient-Selected Music Interventions on Physiological, Psychological, and Quality-of-Life Outcomes	N/A
Completed	`NCT04250987` - Exploratory Investigation of Data Obtained From a Sensor Connected to an Intermittent Catheter	N/A
Completed	`NCT04870632` - Telerehabilitation Improves QoL, Physical Functions and Compliance in Patients With COPD	N/A
Active, not recruiting	`NCT04424238` - the Effect of Mobile Medical Used for the Standardized Management of Gestational Diabetes	N/A
Terminated	`NCT04041908` - Use of a Medical Food in Adults Undergoing Surgery	N/A
Active, not recruiting	`NCT05308914` - Self-Management and Resilience Trajectories in African American Adults With Hypertension
Completed	`NCT06203665` - Restoration of Pulmonary Compliance After Laparoscopic Gynaecologic Surgery Using a Recruitment Maneuver	N/A
Recruiting	`NCT06464003` - Orthodontic Screening in Public Healthcare
Completed	`NCT06055335` - Assessing Lung Dynamics and Respiratory Functions in Minimal Flow Anesthesia: A Prospective Study	N/A
Completed	`NCT03197116` - Lay Tel Compliance Study	N/A
Completed	`NCT03792880` - Global Self-management Telematic Support for Patients With Obstructive Sleep Apnea.	N/A
Recruiting	`NCT04877171` - Telemedicine Efficacy in Medication Adherence in Post-ischemic Stroke Patients	N/A
Recruiting	`NCT05749419` - Vaccinations and People With Disabilities

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Explorative Clinical Study on the Performance and Acceptance of New Intermittent Catheters in Healthy Volunteers

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms